Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-0401 (KUR-111) in Tibial Plateau Fractures
NCT00409799Phase 2Completed
- Sponsor
- Kuros Biosciences
- Start
- Nov 2006
- Primary completion
- Sep 2011
- Modality
- Device-based Delivery
- Countries
- 9
01
Overview
Phase 2, randomised, open-label trial of KUR-111 in tibial plateau fracture (3 arms), sponsored by Kuros Biosciences. Primary endpoint: Radiographic Images. Started Nov 2006; status: completed.
02
Drugs
KUR-111
03
Conditions
tibial plateau fracture
Beyond the preview
Go deeper on NCT00409799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409799.